17. 多系統萎縮症 Multiple system atrophy Clinical trials / Disease details
臨床試験数 : 118 / 薬物数 : 163 - (DrugBank : 49) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04876326 (ClinicalTrials.gov) | October 5, 2020 | 25/4/2021 | Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy | Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy | Multiple System Atrophy;Parkinsonism;Multiple System Atrophy, Parkinson Variant | Biological: Autologous Adipose Mesenchymal Stem Cell Implantation;Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation;Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | Indonesia University | NULL | Recruiting | N/A | N/A | All | 15 | N/A | Indonesia |